Net

2 stories · following the connections

Business

PROVECTUS BIOPHARMACEUTICALS PROVIDES UPDATE ON GI CANCER PROGRAM FOR INVESTIGATIONAL DRUG PV-10

By Nasdaq OMXFeb 22, 2018, 12:01 PM UTC

Business

Privileged Identity Market Growing Rapidly With Stringent Compliance Regulations - IndustryARC Research

By Nasdaq OMXMar 17, 2017, 5:30 PM UTC